Menu Close

2019 Request for Proposals

The 2019 RFP Process Has Concluded

Applications can be submitted in response to this RFA until 5:00PM on October 16, 2019. Applicants will be notified of the funding decision by December 1, 2019, and funded applicants will have a period of 8 months from the notice of award (until July 31, 2020) to complete their projects.

A letter of intent must be submitted to by October 1, 2019, to allow recruitment of external reviewers with subject matter expertise in the proposed area of inquiry.


The Consortium for Medical Marijuana Clinical Outcomes Research is comprised of public and private university member institutions within Florida. The Consortium provides awards to support clinical and translational research related to medical marijuana to investigators within member institutions.

The Consortium is charged by Florida statute to conduct and support research that will contribute to the body of scientific knowledge on the effects of the medical use of marijuana to inform policy and clinical practice related to the treatment of debilitating medical conditions with marijuana.

This award mechanism will consider fully developed research studies that generate novel evidence, as well as studies intended to facilitate the collection and/or analysis of preliminary data that will support future extramural funding applications.


RFA AnnouncementSeptember 16, 2019
Letter of Intent DueOctober 1, 2019
Application DeadlineOctober 16, 2019
Notice of AwardsDecember 1, 2019
Award Funding PeriodDecember 1, 2019 through July 31, 2020


All applicant principal investigators (PIs) must be faculty members of Consortium member institutions, which currently include:

  • Florida A&M University
  • Florida Atlantic University
  • Florida Gulf Coast University
  • Florida Memorial University
  • Florida International University
  • Florida State University
  • University of Central Florida
  • University of Florida
  • University of Miami